• Facebook
  • Twitter
Cancer World Archive
  • Magazine
Homecetuximab

cetuximab

No Picture

Cetuximab dosing by rash ­– is the scaling of EVEREST meaningful?

Number 51

Impact Factor, Senza categoria 1 November 2012 0

The small EVEREST trial has shown that the concept of guiding cetuximab dose escalation using the clinical parameter of acneiform skin rash is safe. However, as no significant increase of cetuximab efficacy could be observed, [more]

No Picture

Newsround

Number 36

Senza categoria 1 May 2010 0

Selected reports edited by Janet Fricker Download full article

No Picture

Newsround

Number 32

Senza categoria 1 September 2009 0

Selected reports edited by Janet Fricker Download full article

No Picture

Newsround

Number 31

Senza categoria 1 July 2009 0

Selected reports edited by Janet Fricker Download full article

No Picture

Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck

Number 30

Impact Factor 1 May 2009 0

Cetuximab increases overall survival in patients with recurrent or metastatic squamous cell carcinomas of the head and neck. Reasonable treatment strategies include the use of first-line platinum, 5-fluorouracil and cetuximab combination, or cetuximab used following [more]

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy